Table 7.
Highest Reported Late GI and GU Toxicity After Completion of SBRT According to CTCAE Criteria.
| Late GI Toxicity | Late GU Toxicity | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Grade | 0 | 1 | 2 | 3 | 4 | 0 | 1 | 2 | 3 | 4 |
| Zilli et al 19 | 7% | 7% | 21% | 29% | 36% | 0% | 21% | 21% | 29% | 29% |
| Vavassori et al 20 | “No patients experienced adverse late effects higher than EORTC/RTOG grade 2” | |||||||||
| Zerini et al 21 | 78% | 16% | 0% | 0% | 0% | 72% | 19% | 3% | 0% | 0% |
| Fuller et al 22 | 100% | 0% | 0% | 0% | 83% | 10% | 3% | 3% | ||
| Janoray et al 23 | 100% | 0% | 0% | 0% | 0% | 95% | 5% | 0% | 0% | 0% |
| Mbeutcha et al 24 | 50% | 0% | 6% | 0% | 0% | 33% | 22% | 6% | 0% | 6% |
| Miszczyk et al | 76% | 8% | 3% | 0% | 0% | 50% | 16% | 16% | 5% | 0% |
Abbreviations: CTCAE, common terminology criteria for adverse events; EORTC/RTOG, European Organization for Research and Treatment of Cancer/Radiation Therapy Oncology Group; GI, gastrointestinal; GU, genitourinary; SABR, stereotactic ablative radiotherapy.
The toxicity in our work was assessed according EORTC/RTOG grading system.